Compare with JUBILANT LIFE SCIENCES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs JUBILANT LIFE SCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES JUBILANT LIFE SCIENCES ALKEM LABORATORIES/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x - 13.6 - View Chart
P/BV x 6.5 1.6 409.7% View Chart
Dividend Yield % 0.7 0.9 71.0%  

Financials

 ALKEM LABORATORIES   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
JUBILANT LIFE SCIENCES
Mar-19
ALKEM LABORATORIES/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs1,589898 176.9%   
Low Rs1,232618 199.5%   
Sales per share (Unadj.) Rs417.5572.0 73.0%  
Earnings per share (Unadj.) Rs56.336.2 155.4%  
Cash flow per share (Unadj.) Rs64.759.5 108.7%  
Dividends per share (Unadj.) Rs12.704.50 282.2%  
Dividend yield (eoy) %0.90.6 151.6%  
Book value per share (Unadj.) Rs292.9301.9 97.0%  
Shares outstanding (eoy) m119.57159.28 75.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.41.3 255.1%   
Avg P/E ratio x25.120.9 119.8%  
P/CF ratio (eoy) x21.812.7 171.2%  
Price / Book Value ratio x4.82.5 191.8%  
Dividend payout %22.612.4 181.6%   
Avg Mkt Cap Rs m168,653120,694 139.7%   
No. of employees `000NA2.4 0.0%   
Total wages/salary Rs m9,17119,260 47.6%   
Avg. sales/employee Rs ThNM38,120.6-  
Avg. wages/employee Rs ThNM8,058.4-  
Avg. net profit/employee Rs ThNM2,414.3-  
INCOME DATA
Net Sales Rs m49,91591,108 54.8%  
Other income Rs m1,645357 460.3%   
Total revenues Rs m51,56191,466 56.4%   
Gross profit Rs m8,48217,390 48.8%  
Depreciation Rs m1,0063,709 27.1%   
Interest Rs m6712,198 30.5%   
Profit before tax Rs m8,45111,840 71.4%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-2,802 0.0%   
Tax Rs m1,6063,268 49.1%   
Profit after tax Rs m6,7315,770 116.7%  
Gross profit margin %17.019.1 89.0%  
Effective tax rate %19.027.6 68.9%   
Net profit margin %13.56.3 212.9%  
BALANCE SHEET DATA
Current assets Rs m27,06245,848 59.0%   
Current liabilities Rs m15,32420,897 73.3%   
Net working cap to sales %23.527.4 85.9%  
Current ratio x1.82.2 80.5%  
Inventory Days Days6757 117.1%  
Debtors Days Days4151 81.0%  
Net fixed assets Rs m12,61065,498 19.3%   
Share capital Rs m239159 150.1%   
"Free" reserves Rs m34,49047,930 72.0%   
Net worth Rs m35,02748,089 72.8%   
Long term debt Rs m1,21242,429 2.9%   
Total assets Rs m54,387114,685 47.4%  
Interest coverage x13.66.4 213.0%   
Debt to equity ratio x00.9 3.9%  
Sales to assets ratio x0.90.8 115.5%   
Return on assets %13.66.9 195.9%  
Return on equity %19.212.0 160.2%  
Return on capital %24.912.4 200.2%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,540NA-   
Fx inflow Rs m6,56312,422 52.8%   
Fx outflow Rs m3,01217,227 17.5%   
Net fx Rs m3,552-4,805 -73.9%   
CASH FLOW
From Operations Rs m7,25911,215 64.7%  
From Investments Rs m1,864-10,118 -18.4%  
From Financial Activity Rs m-9,2736,574 -141.0%  
Net Cashflow Rs m-1507,612 -2.0%  

Share Holding

Indian Promoters % 66.9 45.6 146.7%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 33.1 8.7 380.5%  
FIIs % 0.0 21.2 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 21.1 -  
Shareholders   68,381 23,815 287.1%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SHASUN PHARMA  DR. REDDYS LAB  GSK PHARMA  UNICHEM LAB  WYETH LTD  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 292 Points Higher; Automobile and Metal Stocks Witness Buying(Closing)

After opening the day marginally higher, Indian share markets witnessed buying interest throughout the day and ended on a strong note.

Related Views on News

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY20); Net Profit Down 7.7% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 7.7% YoY). Sales on the other hand came in at Rs 22 bn (up 5.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY19); Net Profit Down 166.0% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 1 bn (down 166.0% YoY). Sales on the other hand came in at Rs 24 bn (up 5.9% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY19); Net Profit Up 25.7% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 25.7% YoY). Sales on the other hand came in at Rs 24 bn (up 15.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Oct 15, 2019 03:37 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS